A medication used to treat inflammatory bowel disease by reducing intestinal inflammation, thereby relieving abdominal pain, diarrhea, and rectal bleeding while maintaining remission.
Indications:
- Treatment of mildly to moderately active ulcerative colitis.
- Maintenance of remission in ulcerative colitis.
- Maintenance of remission of Crohn's ileocolitis and other forms of inflammatory bowel disease.
Main Active Ingredient:
- Mesalazine 500 mg.
Precautions:
- Regular monitoring of kidney and liver function is recommended during treatment.
- Not suitable for individuals allergic to mesalazine, salicylates, or sulfasalazine.
- Use with caution in patients with asthma, heart conditions, or renal impairment.
- Ensure adequate fluid intake to reduce the risk of kidney stones.
Side Effects:
- Headache or dizziness.
- Nausea, vomiting, or abdominal discomfort.
- Rash, itching, or allergic skin reactions.
- Rare cases of blood disorders, liver or kidney problems.
Drug-Drug Interactions:
- Anticoagulants such as warfarin.
- Immunosuppressants such as azathioprine, 6-mercaptopurine, or thioguanine.
- Non-steroidal anti-inflammatory drugs (NSAIDs).
- Methotrexate and sulfonylureas.
- Certain diuretics such as spironolactone and furosemide.
- Take one tablet orally before meals with sufficient water.
- Do not chew, split, or crush the tablet, as it is gastro-resistant and designed to release the active ingredient in the intestines.
- Always follow your doctor’s prescribed dosage and treatment schedule.
Mesalazine, Sodium Carbonate Anhydrous, Glycine, Povidone, Microcrystalline Cellulose, Croscarmellose Sodium, Colloidal Anhydrous Silica, Calcium Stearate, Methacrylic Acid–Ethyl Acrylate Copolymer (1:1) Dispersion 30%, Methacrylic Acid–Methyl Methacrylate Copolymer (1:1), Methacrylic Acid–Methyl Methacrylate Copolymer (1:2), Dibutyl Sebacate, Talc, Titanium Dioxide (E171), Macrogol, Yellow Iron Oxide (E172), Red Iron Oxide (E172), Povidone.
Mesalazine
